Connection
Anunta Virapongse to Cost-Benefit Analysis
This is a "connection" page, showing publications Anunta Virapongse has written about Cost-Benefit Analysis.
|
|
Connection Strength |
|
|
|
|
|
0.015 |
|
|
|
-
Rothberg MB, Virapongse A, Smith KJ. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clin Infect Dis. 2007 May 15; 44(10):1280-8.
Score: 0.015